Goldspan Health Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.9/10
Best for: upfront-priced compounded semaglutide or tirzepatide with B12 or glycine, from a brand-new storefront
Goldspan Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $229 a month; its compounded tirzepatide, at $299, is 11% above the $269 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Goldspan Health is a new storefront selling compounded semaglutide and tirzepatide, each blended with B12 or glycine. Prescribing, pharmacy and billing run through Altro Health, the telehealth platform operated by Lyv Health, Inc., and its affiliated medical group. Semaglutide is $229 and tirzepatide $299 a month, billed every 28 days, with the clinician visit, medication, supplies and 2-day shipping included. Orders are final sale, and a lab panel is required within 60 to 90 days.
Is Goldspan Health legit?
Yes. Goldspan Health is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.9/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Goldspan Health promo or coupon code?
We know of no promo or coupon code for Goldspan Health. Its listed price is $229 a month. Coupon sites advertising "Goldspan Health discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Goldspan Health compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Goldspan Health
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
from $229/mo · no insurance needed
Goldspan Health at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $229/mo
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How Goldspan Health scores
Six columns, each one computed from something Goldspan Health has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.2/10$299/month is 11% above the $269 median for compounded tirzepatide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
7.5/10A price is shown before the questionnaire starts. Baseline bloodwork is required before a prescription.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Goldspan Health
Last checked October 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Goldspan Health
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Goldspan Health involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Goldspan Health shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2The intake requires baseline bloodwork before a first prescription, which takes longer than a written form and is the more careful route.
- 3Ask Goldspan Health which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $229, tirzepatide $299. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that Goldspan Health serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Goldspan Health
- Goldspan Health offers email support
Cancelling Goldspan Health
Taken from the terms Goldspan Health publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- Monthly plan billed every 28 days; renews automatically until canceled
- Refund policy
- "All orders for Products are final sale and may not be refunded for any reason"
- Early-termination fee
- None
Medications Goldspan Health lists
Goldspan Health lists compounded semaglutide and compounded tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Billed every 28 days, so a year is thirteen charges. Includes the clinician evaluation, medication, injection supplies and 2-day shipping. The B12 and glycine versions cost the same.
Billed every 28 days, so a year is thirteen charges. Includes the clinician evaluation, medication, injection supplies and 2-day shipping. The B12 and glycine versions cost the same.
Check the price yourself before you pay
Every figure here comes from Goldspan Health's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Goldspan Health
- Baseline bloodwork is required before a prescription
Against it
- Semaglutide costs $229 a month, 15% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $299 a month, 11% above the $269 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Goldspan Health charges
The standing price at Goldspan Health is $229/month.
- Compounded semaglutide: $229/month
- Compounded tirzepatide: $299/month
For compounded tirzepatide, the median across the sellers we compare is $269/month, so Goldspan Health's $299 lands mid-market. Price is unlikely to be the deciding factor. Before you pay, compare Goldspan Health's cancellation terms with other sellers' cancellation and refund policies.
Belle Health dispenses semaglutide and tirzepatide from $199/month, which makes it the fair comparison to run before you commit here.
What Goldspan Health dispenses
Goldspan Health prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. Some of Goldspan Health's preparations are mixed with B12; why compounders add it separates what is established from what is only claimed.
Safety and disclosure
Goldspan Health tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. We found no FDA warning letters issued to Goldspan Health. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Goldspan Health will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to cover the cost. Check whether Goldspan Health bills your plan before you start.
It fits if
- you need access wherever you live
Our read
Goldspan Health lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. Wellorithm is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Goldspan Health scores highest on the clinical side (which drugs it prescribes and how it doses) and lowest on price. It charges from $229 a month; its compounded tirzepatide, at $299, is 11% above the $269 median among the sellers we compare.
Before you pay Goldspan Health
Starting at $229 a month. Check today's price, then start the intake.
Where Goldspan Health is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider WellMedRx.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo + membership).
- If you want a human checking in, not just a prescription, consider Eden.
If none of these fits, our guide to alternatives to Goldspan Health sets more sellers in the same category beside Goldspan Health on price, states and what the price includes.
Frequently Asked Questions
How to check Goldspan Health yourself
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Goldspan Health review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Goldspan Health's current pricing
Plans start at $229 a month. Whether you qualify is a clinician's decision, made after your intake.